Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Repression Of Cyclin D1: A Novel Function Of MYC.

A. Philipp, A. Schneider, I. Väsrik, K. Finke, Y. Xiong, D. Beach, K. Alitalo, M. Eilers
Published 1994 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Constitutive expression of human MYC represses mRNA levels of cyclin D1 in proliferating BALB/c-3T3 fibroblasts. We expressed a series of mutant alleles of MYC and found that downregulation of cyclin D1 is distinct from previously described properties of MYC. In particular, we found that association with Max is not required for repression of cyclin D1 by MYC in vivo. Conversely, the integrity of a small amino-terminal region (amino acids 92 to 106) of MYC is critical for repression of cyclin D1 but dispensable for transformation of established RAT1A cells. Runoff transcription assays showed that repression occurs at the level of transcription initiation. We cloned the promoter of the gene for human cyclin D1 and found that it lacks a canonical TATA element. Transcription starts at an initiator element similar to that of the adenovirus major late promoter; this element can be directly bound by USF in vitro. Expression of MYC represses the cyclin D1 promoter via core promoter elements and antagonizes USF-mediated transactivation. Taken together, our data define a new pathway for gene regulation by MYC and show that the cyclin D1 gene is a target gene for repression by MYC.
This paper references
10.1073/PNAS.79.8.2490
Expression of cellular homologues of retroviral onc genes in human hematopoietic cells.
E. Westin (1982)
10.1016/0092-8674(92)90123-T
Induction of apoptosis in fibroblasts by c-myc protein
G. Evan (1992)
10.1089/DNA.1988.7.219
Construction and characterization of a retroviral vector demonstrating efficient expression of cloned cDNA sequences.
P. Kirschmeier (1988)
10.1128/MCB.12.9.3919
Growth factor-induced delayed early response genes.
A. Lanahan (1992)
Induction of cyclin DI and cyclin-E and suppression of cdk2 and cdk4 in senescent human cells
F C Lucibello (1993)
10.1128/MCB.11.11.5446
Expression of CD44 is repressed in neuroblastoma cells.
E. Shtivelman (1991)
10.1101/gad.3.6.860
Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo.
K. M. Downs (1989)
10.1101/GAD.6.12A.2429
Biphasic effect of Max on Myc cotransformation activity and dependence on amino- and carboxy-terminal Max functions.
G. Prendergast (1992)
10.1101/GAD.7.3.331
Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4.
J. Kato (1993)
10.1093/NAR/13.5.1431
Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family.
P. Fort (1985)
10.1101/GAD.7.5.812
Cyclin D1 is a nuclear protein required for cell cycle progression in G1.
V. Baldin (1993)
Molecular Cloning: A Laboratory Manual
J. Sambrook (1983)
10.1016/S0065-230X(08)60476-5
Control of c-myc regulation in normal and neoplastic cells.
C. Spencer (1991)
10.1101/GAD.6.9.1810
Conserved motifs in Fos and Jun define a new class of activation domain.
J. A. Sutherland (1992)
10.1002/j.1460-2075.1993.tb06202.x
The c‐Myc protein induces cell cycle progression and apoptosis through dimerization with Max.
B. Amati (1993)
Increased cyclin A and decreased cyclin D levels in adenovirus 5 E1A-transformed rodent cell lines.
T. Buchou (1993)
10.1007/978-3-540-29678-2_5130
Retroviral vectors.
G. Anton (1994)
Regulation of cell cycle duration by c-myc levels.
J. Karn (1989)
10.1126/SCIENCE.8266081
Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc.
A. Shrivastava (1993)
10.1038/301722A0
Identification and nucleotide sequence of a human locus homologous to the v-myc oncogene of avian myelocytomatosis virus MC29
W. Colby (1983)
10.1128/MCB.11.4.2291
Transcriptional suppression of cellular gene expression by c-Myc.
B. S. Yang (1991)
The role of ras and myc oncogenes in human solid tumours and their relevance in diagnosis and prognosis (review).
J. Field (1990)
10.1016/0925-4773(91)90078-K
A comparative analysis of N-myc and c-myc expression and cellular proliferation in mouse organogenesis
U. Hirning (1991)
10.1002/j.1460-2075.1991.tb07929.x
The MYC protein activates transcription of the alpha‐prothymosin gene.
M. Eilers (1991)
10.1016/0003-2697(87)90021-2
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
P. Chomczyński (1987)
10.1038/354245A0
Cooperative interaction of an initiator-binding transcription initiation factor and the helix–loop–helix activator USF
A. Roy (1991)
10.1016/0092-8674(84)90012-6
Fibroblast lines expressing activated c-myc oncogenes are tumorigenic in nude mice and syngeneic animals
E. Keath (1984)
10.1002/j.1460-2075.1993.tb05682.x
Human transcription factor USF stimulates transcription through the initiator elements of the HIV‐1 and the Ad‐ML promoters.
H. Du (1993)
10.1016/0092-8674(91)90457-A
Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation
G. Prendergast (1991)
Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells.
M. Pagano (1992)
10.1073/PNAS.90.16.7804
The ornithine decarboxylase gene is a transcriptional target of c-Myc.
C. Bello-Fernandez (1993)
10.1128/MCB.10.11.5914
An amino-terminal c-myc domain required for neoplastic transformation activates transcription.
G. Kato (1990)
10.1002/j.1460-2075.1990.tb08217.x
Negative autoregulation of c‐myc transcription.
L. Penn (1990)
10.1101/GAD.6.1.71
Myc and Max associate in vivo.
E. Blackwood (1992)
10.1126/SCIENCE.1987636
Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region.
G. Prendergast (1991)
10.1002/j.1460-2075.1993.tb05777.x
The NF‐M transcription factor is related to C/EBP beta and plays a role in signal transduction, differentiation and leukemogenesis of avian myelomonocytic cells.
Sophie Katz (1993)
10.1073/PNAS.79.7.2194
Differential expression of the amv gene in human hematopoietic cells.
E. Westin (1982)
10.1073/PNAS.84.1.170
Evolutionarily conserved regions of the human c-myc protein can be uncoupled from transforming activity.
J. Sarid (1987)
Genes Dev
10.1128/JVI.68.4.2206-2214.1994
Modulation of cyclin gene expression by adenovirus E1A in a cell line with E1A-dependent conditional proliferation.
D. Spitkovsky (1994)
10.1016/0092-8674(93)90137-F
Physical interaction of the retinoblastoma protein with human D cyclins
S. Dowdy (1993)
10.1038/359423A0
Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max
B. Amati (1992)
10.1101/GAD.7.8.1559
Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.
D. Quelle (1993)
10.1016/0092-8674(91)90101-4
Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
H. Matsushime (1991)
10.1016/0304-419X(92)90011-M
The functions of Myc proteins.
A. Meichle (1992)
Luciferase reporter gene vectors for analysis of promoters and enhancers.
S. Nordeen (1988)
10.1038/365355A0
An alternative pathway for transcription initiation involving TFII-I
A. Roy (1993)
10.1038/350512A0
A novel cyclin encoded by a bcl1-linked candidate oncogene
T. Motokura (1991)
10.1038/354241A0
YY1 is an initiator sequence-binding protein that directs and activates transcription in vitro
E. Seto (1991)
Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation.
H. Lovec (1994)
10.1038/340066A0
Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells
M. Eilers (1989)
J. Virol
10.1016/0962-8924(92)90129-B
Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport
J. Pines (1992)
10.1128/MCB.14.6.3853
An E-box element localized in the first intron mediates regulation of the prothymosin alpha gene by c-myc.
S. Gaubatz (1994)
10.1101/GAD.6.12B.2513
An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence.
N. Benvenisty (1992)
10.1016/0092-8674(93)90663-B
Oncogenic activity of the c-Myc protein requires dimerization with Max
B. Amati (1993)
10.1016/0092-8674(92)90249-C
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
P. Hinds (1992)
10.1128/JVI.62.4.1120-1124.1988
A safe packaging line for gene transfer: separating viral genes on two different plasmids.
D. Markowitz (1988)
Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
W. Jiang (1993)
10.1128/MCB.13.12.7358
Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E.
I. Rosenwald (1993)
10.1128/MCB.10.5.2012
N-myc down regulates neural cell adhesion molecule expression in rat neuroblastoma.
R. Akeson (1990)
10.1016/0092-8674(83)90092-2
Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor
K. Kelly (1983)
10.1073/PNAS.80.8.2146
Nucleotide sequence analysis of the chicken c-myc gene reveals homologous and unique coding regions by comparison with the transforming gene of avian myelocytomatosis virus MC29, delta gag-myc.
D. Watson (1983)
10.1126/science.2006410
Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.
E. Blackwood (1991)
10.1016/0092-8674(93)90636-5
Mammalian G1 cyclins
C. Sherr (1993)
10.1128/MCB.7.5.1697
Definition of regions in human c-myc that are involved in transformation and nuclear localization.
J. Stone (1987)
10.1016/0092-8674(93)90136-E
Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
M. Ewen (1993)
10.1126/science.256.5055.373
Alternative Forms of Max as Enhancers or Suppressors of Myc-Ras Cotransformation
Tomi P. M�kel� (1992)
10.1126/SCIENCE.2251503
Sequence-specific DNA binding by the c-Myc protein.
T. Blackwell (1990)
10.1128/MCB.13.1.383
Sequence-specific transcriptional activation by Myc and repression by Max.
C. Amin (1993)
TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights.
H. Moses (1990)
DNA-binding specificity of USF, a human gene-specific transcription factor required for maximum expression of the major late promoter of adenovirus
M Sawadogo (1987)
10.1073/PNAS.91.8.2945
Cyclin D1 expression is regulated by the retinoblastoma protein.
H. Mueller (1994)
10.1016/0968-0004(92)90435-C
The cell cycle then and now.
M. Kirschner (1992)
10.1126/SCIENCE.6463648
Nuclear localization and DNA binding properties of a protein expressed by human c-myc oncogene.
H. Persson (1984)
10.1128/MCB.4.11.2486
Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells.
S. Hann (1984)
Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines.
J. Lukas (1994)
10.1128/MCB.5.12.3610
Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.
G. Evan (1985)
10.1002/j.1460-2075.1990.tb07469.x
Role of the two activating domains of the oestrogen receptor in the cell‐type and promoter‐context dependent agonistic activity of the anti‐oestrogen 4‐hydroxytamoxifen.
M. Berry (1990)
10.1128/MCB.11.1.354
c-myc reverses neu-induced transformed morphology by transcriptional repression.
T. Suen (1991)
10.1016/0092-8674(78)90225-8
Transformation parameters in chicken fibroblasts transformed by AEV and MC29 avian leukemia viruses
B. Royer-pokora (1978)
10.1073/PNAS.89.20.9910
Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts.
K. Won (1992)
c-Myc induces the expression and activity of ornithine decarboxylase.
A. Wagner (1993)
10.1073/PNAS.86.14.5400
Regulated expression of foreign genes in mammalian cells under the control of coliphage T3 RNA polymerase and lac repressor.
U. Deuschle (1989)
10.1093/NAR/16.15.7351
A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions.
R. Higuchi (1988)
10.1038/359426A0
Myc and Max proteins possess distinct transcriptional activities
L. Kretzner (1992)



This paper is referenced by
10.1021/pr301055y
Hsp90 Inhibitor SNX-7081 dysregulates proteins involved with DNA repair and replication and the cell cycle in human chronic lymphocytic leukemia (CLL) cells.
Yiping Che (2013)
10.1128/MCB.15.8.4031
A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain.
A. T. Hoang (1995)
Endocrine-Related Cancer ( 2000 ) 7 143 – 164 c-Myc in breast cancer
D. J. Liao (2000)
8. Cyc1ins and breast cancer
E. Musgrove (1996)
Integrative Bioinformatics Approaches toward Systems-level Understanding of Breast Cancers
L. Huang (2012)
10.1158/1078-0432.CCR-12-0977
c-Myc and Cancer Metabolism
D. Miller (2012)
10.1124/mol.109.054858
Stabilizers of the Max Homodimer Identified in Virtual Ligand Screening Inhibit Myc Function
H. Jiang (2009)
10.1002/j.1460-2075.1996.tb00669.x
Activation of cyclin‐dependent kinases by Myc mediates induction of cyclin A, but not apoptosis.
B. Rudolph (1996)
Cell Cycle Arrest and Repression of Cyclin D 1 Transcription by INI 1 / hSNF 5
Zhikai Zhang (2002)
Protéines à doigts de zinc se liant à l'oncogène mycm ainsi comment leur préparation et utilisation
M. Eilers (1998)
10.1038/onc.2009.368
Enhanced mRNA cap methylation increases Cyclin D1 expression and promotes cell transformation
V. Cowling (2010)
10.1074/jbc.272.52.33181
Transforming Growth Factor-α Enhances Cyclin D1 Transcription through the Binding of Early Growth Response Protein to a cis-Regulatory Element in the Cyclin D1 Promoter*
Y. X. Yan (1997)
10.1074/JBC.M103793200
How Transcriptional Activators Bind Target Proteins*
S. Hermann (2001)
Targeting of the Myc pathway as a novel approach for cancer therapy
H. Mo (2006)
10.1002/j.1460-2075.1995.tb00163.x
Identification of a Myc‐dependent step during the formation of active G1 cyclin‐cdk complexes.
P. Steiner (1995)
10.1074/jbc.273.45.29864
Cyclin D Expression Is Controlled Post-transcriptionally via a Phosphatidylinositol 3-Kinase/Akt-dependent Pathway*
R. Muise-Helmericks (1998)
A Lasorella, a Iavarone and M a Israel Cycle by Tumor Suppressor Proteins. Id2 Specifically Alters Regulation of the Cell
()
Rola TGF-b w regulacji cyklu komórkowego* The role of TGF-b in cell cycle regulation
Liliana Stalińska (2005)
10.1158/1078-0432.CCR-06-1844
c-Myc–Induced Chemosensitization Is Mediated by Suppression of Cyclin D1 Expression and Nuclear Factor-κB Activity in Pancreatic Cancer Cells
H. Biliran (2007)
10.1074/jbc.274.48.34186
Activation of the cyclin D1 Gene by the E1A-associated Protein p300 through AP-1 Inhibits Cellular Apoptosis*
C. Albanese (1999)
Proteomic analysis of HSP90 inhibitor effects on human leukemia cells
Yiping Che (2013)
10.4161/cbt.11.7.14688
c-Myc induction of programmed cell death may contribute to carcinogenesis
C. Wang (2011)
10.1038/nm0795-638
Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells
J. Chen (1995)
10.1002/jcp.20649
Phosphorylation regulates Myc expression via prolonged activation of the mitogen‐activated protein kinase pathway
Z. Wang (2006)
10.1128/MCB.00273-18
Decreased c-Myc mRNA Stability via the MicroRNA 141-3p/AUF1 Axis Is Crucial for p63α Inhibition of Cyclin D1 Gene Transcription and Bladder Cancer Cell Tumorigenicity
X. Li (2018)
10.4161/cc.5.4.2442
TFII-I: Connecting Mitogenic Signals to Cell Cycle Regulation
Zana P Desgranges (2006)
Targeting of the Myc pathway as a novel approach for cancer therapy
H. Mo (2006)
10.1074/JBC.M207196200
Identification of a Novel Krüppel-associated Box Domain Protein, Krim-1, That Interacts with c-Myc and Inhibits Its Oncogenic Activity*
H. Hennemann (2003)
growth-related gene . genes : characterization of rcl , a novel Identification of putative c-Myc-responsive
B. Lewis (1997)
10.1128/MCB.18.10.5961
myc Boxes, Which Are Conserved in myc Family Proteins, Are Signals for Protein Degradation via the Proteasome
E. M. Flinn (1998)
10.1046/j.1365-2443.1996.00259.x
D‐type cyclin expression is decreased and p21 and p27 CDK inhibitor expression is increased when tsBN462 CCG1/TAFII250 mutant cells arrest in G1 at the restrictive temperature
T. Sekiguchi (1996)
10.1006/BBRC.2000.2316
Inhibition of adipocyte differentiation by cMyc is not accompanied by alterations in cell cycle control.
V. Heath (2000)
See more
Semantic Scholar Logo Some data provided by SemanticScholar